People: Sun Pharmaceutical Industries Ltd (SUN.BO)
22 Nov 2017
Mr. Dilip Shantilal Shanghvi serves as Managing Director, Executive Director of Sun Pharmaceutical Industries Limited. He resigned as Executive Chairman of the Board of the Company, effective May 28, 2012. He is a graduate from Calcutta University and has launched Sun Pharma in 1982 and carries industrial experience in the Pharmaceutical industry and at present he is the Chairman and Managing Director of the Company. His other directorships includes: Caraco Pharmaceutical Laboratories Ltd., Detroit, USA, Sun Speciality Chemicals Pvt. Ltd., Sun Resins & Polymers Pvt. Ltd., Sun Fastfin Services Pvt. Ltd., Sun Petrochemicals Private Limited, SPARC Bio-Research Private Limited, Sun Pharma Global Inc., British Virgin Island, Sun Pharma De Mexico SA DE CV, SPIL De Mexico SA DE CV and Shantilal Shanghvi Foundation.
|Total Annual Compensation, INR||17,661,400|
|Restricted Stock Awards, INR||--|
|Long-Term Incentive Plans, INR||--|
|All Other, INR||2,717,370|
|Fiscal Year Total, INR||20,378,800|